Literature DB >> 16188881

Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen.

Gil Zomber1, Shaul Reuveny, Nissim Garti, Avigdor Shafferman, Eytan Elhanany.   

Abstract

Protective antigen (PA) is a central virulence factor of Bacillus anthracis and a key component in anthrax vaccines. PA binds to target cell receptors, is cleaved by the furin protease, self-aggregates to heptamers, and finally internalizes as a complex with either lethal or edema factors. Under mild room temperature storage conditions, PA cytotoxicity decreased (t(1/2) approximately 7 days) concomitant with the generation of new acidic isoforms, probably through deamidation of Asn residues. Ranking all 68 Asn residues in PA based on their predicted deamidation rates revealed five residues with half-lives of <60 days, and these residues were further analyzed: Asn10 in the 20-kDa region, Asn162 at P6 vicinal to the furin cleavage site, Asn306 in the pro-pore translocation loop, and both Asn713 and Asn719 in the receptor-binding domain. We found that PA underwent spontaneous deamidation at Asn162 upon storage concomitant with decreased susceptibility to furin. A panel of model synthetic furin substrates was used to demonstrate that Asn162 deamidation led to a 20-fold decrease in the bimolecular rate constant (k(cat)/Km) of proteolysis due to the new negatively charged residue at P6 in the furin recognition sequence. Furthermore, reduced PA cytotoxicity correlated with a decrease in PA cell binding and also with deamidation of Asn713 and Asn719. On the other hand, neither deamidation of Asn10 or Asn306 nor impairment of heptamerization could be observed upon prolonged PA storage. We suggest that PA inactivation during storage is associated with susceptible deamidation sites, which are intimately involved in both mechanisms of PA cleavage by furin and PA-receptor binding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188881     DOI: 10.1074/jbc.M508569200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

2.  Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits.

Authors:  Qin Li; Kristina K Peachman; Laurie Sower; Stephen H Leppla; Sathish B Shivachandra; Gary R Matyas; Johnny W Peterson; Carl R Alving; Mangala Rao; Venigalla B Rao
Journal:  Open Vaccine J       Date:  2009

3.  Evidence of the involvement of asparagine deamidation in the formation of cyclodextrin glycosyltransferase isoforms in Paenibacillus sp. RB01.

Authors:  Wanchai Yenpetch; Kanoktip Packdibamrung; Wolfgang Zimmermann; Piamsook Pongsawasdi
Journal:  Mol Biotechnol       Date:  2011-03       Impact factor: 2.695

4.  Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease.

Authors:  Miriam A Balderas; Chinh T Q Nguyen; Austen Terwilliger; Wendy A Keitel; Angelina Iniguez; Rodrigo Torres; Frederico Palacios; Celia W Goulding; Anthony W Maresso
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

5.  Differential proteomic analysis of the Bacillus anthracis secretome: distinct plasmid and chromosome CO2-dependent cross talk mechanisms modulate extracellular proteolytic activities.

Authors:  Theodor Chitlaru; Orit Gat; Yael Gozlan; Naomi Ariel; Avigdor Shafferman
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

6.  Analysis and identification of ADP-ribosylated proteins of Streptomyces coelicolor M145.

Authors:  András Penyige; Judit Keseru; Ferenc Fazakas; Iván Schmelczer; Krisztina Szirák; György Barabás; Sándor Biró
Journal:  J Microbiol       Date:  2009-10-24       Impact factor: 3.422

7.  Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of Bacillus anthracis protective antigen.

Authors:  Anita Verma; Beth McNichol; Rocío I Domínguez-Castillo; Juan C Amador-Molina; Juan L Arciniega; Karine Reiter; Bruce D Meade; Miriam M Ngundi; Scott Stibitz; Drusilla L Burns
Journal:  Infect Immun       Date:  2012-10-31       Impact factor: 3.441

8.  Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

Authors:  Anna U Bielinska; Katarzyna W Janczak; Jeffrey J Landers; Paul Makidon; Laurie E Sower; Johnny W Peterson; James R Baker
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

9.  A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.

Authors:  Manish Manish; Amit Rahi; Manpreet Kaur; Rakesh Bhatnagar; Samer Singh
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

10.  GH1-family 6-P-β-glucosidases from human microbiome lactic acid bacteria.

Authors:  Karolina Michalska; Kemin Tan; Hui Li; Catherine Hatzos-Skintges; Jessica Bearden; Gyorgy Babnigg; Andrzej Joachimiak
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.